{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:38:32Z","timestamp":1790951912198,"version":"4.1.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Human immunodeficiency virus (HIV) prevention interventions for prevention interventions for women include screening, partner notification, promoting condoms, and preexposure prophylaxis (PrEP). Women\u2019s risk of acquiring HIV can help guide recommendations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We used data from Louisiana\u2019s sexually transmitted infection (STI) and HIV registries to study 13- to 59-year-old women following first diagnosis of syphilis, gonorrhea, or chlamydia during 2000\u20132015. We measured HIV rates reported subsequent to STI (through 2016). Rates for women without STI were estimated by subtracting women with STI from reported cases and from Census estimates for the population. PrEP cost was estimated as $11 000 per year, and effectiveness estimated as 100%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>STIs were syphilis (6574), gonorrhea (64 995), or chlamydia (140 034). These 211 603 women had 1 865 488 person-years of follow-up and 969 HIV diagnoses. Women with no STI had 5186 HIV diagnoses over 24 359 397 person-years. HIV rates diagnosis (per 100 000 person-years) were higher for women after syphilis (177.3), gonorrhea (73.2), or chlamydia (35.4) compared to women with no STI (22.4). Providing PrEP to all women diagnosed with syphilis or gonorrhea would cost $7 371 111 000 and could have prevented 546 HIV diagnoses. Limiting PrEP to 1 year after syphilis or gonorrhea diagnosis would cost $963 847 334, but only 143 HIV diagnoses were within 2 years after a syphilis or gonorrhea diagnosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Rates of HIV diagnosis were high after women had STI, but not high enough to make PrEP cost-effective for them. Most women diagnosed with HIV did not have previously reported STI.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciz303","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T19:57:43Z","timestamp":1554839863000},"page":"1115-1120","source":"Crossref","is-referenced-by-count":13,"title":["Rates of New Human Immunodeficiency Virus (HIV) Diagnoses After Reported Sexually Transmitted Infection in Women in Louisiana, 2000\u20132015: Implications for HIV Prevention"],"prefix":"10.1093","volume":"70","author":[{"given":"Daniel R","family":"Newman","sequence":"first","affiliation":[{"name":"Division of sexually transmitted diseases (STD) Prevention, National Center for Human Immunodeficiency Virus (HIV), Hepatitis, STD, and tuberculosis Prevention, Centers for Disease Control and Prevention , Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad M","family":"Rahman","sequence":"additional","affiliation":[{"name":"Division of sexually transmitted diseases (STD) Prevention, National Center for Human Immunodeficiency Virus (HIV), Hepatitis, STD, and tuberculosis Prevention, Centers for Disease Control and Prevention , Atlanta, Georgia"},{"name":"STD\/HIV Program, Louisiana Department of Health , New Orleans"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Brantley","sequence":"additional","affiliation":[{"name":"STD\/HIV Program, Louisiana Department of Health , New Orleans"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A","family":"Peterman","sequence":"additional","affiliation":[{"name":"Division of sexually transmitted diseases (STD) Prevention, National Center for Human Immunodeficiency Virus (HIV), Hepatitis, STD, and tuberculosis Prevention, Centers for Disease Control and Prevention , Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"key":"2024111411410574400_CIT0001","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11904-012-0114-z","article-title":"HIV-1 prevention for HIV-1 serodiscordant couples","volume":"9","author":"Curran","year":"2012","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2024111411410574400_CIT0002","doi-asserted-by":"crossref","first-page":"497","DOI":"10.7326\/0003-4819-149-7-200810070-00011","article-title":"Behavioral counseling to prevent sexually transmitted infections: a systematic review for the U.S. Preventive Services Task Force","volume":"149","author":"Lin","year":"2008","journal-title":"Ann Intern Med"},{"key":"2024111411410574400_CIT0003","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/01.qai.0000151079.33935.79","article-title":"Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs","volume":"39","author":"Marks","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024111411410574400_CIT0004","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/infdis\/jir747","article-title":"Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples","volume":"205","author":"Hughes","year":"2012","journal-title":"J Infect Dis"},{"key":"2024111411410574400_CIT0005","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"key":"2024111411410574400_CIT0006","first-page":"CD002835","article-title":"Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure","volume":"1","author":"Young","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2024111411410574400_CIT0007","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana","volume":"367","author":"Thigpen","year":"2012","journal-title":"N Engl J Med"},{"key":"2024111411410574400_CIT0008","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"key":"2024111411410574400_CIT0009","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.amepre.2016.01.011","article-title":"Cost effectiveness of HIV prevention interventions in the U.S","volume":"50","author":"Lin","year":"2016","journal-title":"Am J Prev Med"},{"key":"2024111411410574400_CIT0010","doi-asserted-by":"crossref","first-page":"e11094","DOI":"10.1371\/journal.pone.0011094","article-title":"A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008","volume":"5","author":"Rehle","year":"2010","journal-title":"PLoS One"},{"key":"2024111411410574400_CIT0011","doi-asserted-by":"crossref","first-page":"e000626","DOI":"10.1136\/bmjopen-2011-000626","article-title":"HIV incidence and prevalence among cohorts of women with higher risk behavior in Bloemfontein and Rustenberg, South Africa: a prospective study","volume":"2","author":"Feldblum","year":"2012","journal-title":"BMJ Open"},{"key":"2024111411410574400_CIT0012","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure prophylaxis for HIV infection among African women","volume":"367","author":"Van Damme","year":"2012","journal-title":"N Engl J Med"},{"key":"2024111411410574400_CIT0013","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00042560-199903010-00013","article-title":"Incidence and risk factors for heterosexually acquired HIV in an inner-city cohort of women: temporal association with pregnancy","volume":"20","author":"Chirgwin","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"2024111411410574400_CIT0014","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF02386751","article-title":"Involving women in HIV vaccine efficacy trials: lessons learned from a vaccine preparedness study in New York City","volume":"77","author":"Brown-Peterside","year":"2000","journal-title":"J Urban Health"},{"key":"2024111411410574400_CIT0015","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/aje\/153.7.619","article-title":"Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study","volume":"153","author":"Seage","year":"2001","journal-title":"Am J Epidemiol"},{"key":"2024111411410574400_CIT0016","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/QAI.0b013e3181b7222e","article-title":"A randomized trial of enhanced HIV risk-reduction and vaccine trial education interventions among HIV-negative, high-risk women who use noninjection drugs: the UNITY study","volume":"53","author":"Koblin","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024111411410574400_CIT0017","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/QAI.0b013e31828ded1a","article-title":"Feasibility of identifying a cohort of US women at high risk for HIV infection for HIV vaccine efficacy trials: longitudinal results of HVTN 906","volume":"63","author":"Koblin","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024111411410574400_CIT0018","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/0003-4819-158-1-201301010-00004","article-title":"HIV acquisition among women from selected areas of the United States: a cohort study","volume":"158","author":"Hodder","year":"2013","journal-title":"Ann Intern Med"},{"key":"2024111411410574400_CIT0019","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1097\/QAD.0b013e328360c83e","article-title":"Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition","volume":"27","author":"Novak","year":"2013","journal-title":"AIDS"},{"key":"2024111411410574400_CIT0020","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/cid\/cix313","article-title":"US black women and human immunodeficiency virus prevention: time for new approaches to clinical trials","volume":"65","author":"Adimora","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2024111411410574400_CIT0021","author":"Centers for Disease Control and Prevention,"},{"key":"2024111411410574400_CIT0022","volume-title":"Sexually transmitted disease surveillance 2016","author":"Centers for Disease Control and Prevention"},{"key":"2024111411410574400_CIT0023","volume-title":"HIV in the United States by Region","author":"Centers for Disease Control and Prevention"},{"key":"2024111411410574400_CIT0024","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/0956462414531243","article-title":"Risk for HIV following a diagnosis of syphilis, gonorrhea or chlamydia: 328,456 women in Florida, 2000\u20132011","volume":"26","author":"Peterman","year":"2015","journal-title":"Int J STD AIDS"},{"key":"2024111411410574400_CIT0025","author":"United States Census Bureau","year":"2010"},{"key":"2024111411410574400_CIT0026","author":"New York State Department of Health","year":"2012"},{"key":"2024111411410574400_CIT0027","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.2196\/publichealth.5684","article-title":"Rates of prevalent HIV infection, prevalent diagnoses, and new diagnoses among men who have sex with men in US states, metropolitan statistical areas, and counties, 2012\u20132013","volume":"2","author":"Rosenberg","year":"2016","journal-title":"JMIR Public Health Surveill"},{"key":"2024111411410574400_CIT0028","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/OLQ.0000000000000802","article-title":"New human immunodeficiency virus diagnoses among men who have sex with men attending sexually transmitted disease clinics, STD Surveillance Network, January 2010 to June 2013","volume":"45","author":"Llata","year":"2018","journal-title":"Sex Transm Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciz303\/28761144\/ciz303.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/70\/6\/1115\/32756691\/ciz303.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/70\/6\/1115\/32756691\/ciz303.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T12:29:43Z","timestamp":1731587383000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/70\/6\/1115\/5446594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,4,12]]},"published-print":{"date-parts":[[2020,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz303","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3,15]]},"published":{"date-parts":[[2019,4,12]]}}}